Baloro, Jesrel C.
HRN: 23-89-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/05/2024
06/11/2024
IV
400mg
Q6h
PCAP C
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes